Millennium Management
DAWN

Millennium Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Millennium Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.3M Buy
1,927,557
+577,638
+43% +$8.14M 0.02% 969
2025
Q4 		$12.6M Buy
1,349,919
+656,599
+95% +$5.49M 0.01% 2016
2025
Q3 		$4.89M Sell
693,320
-514,482
-43% -$3.54M ﹤0.01% 3179
2025
Q2 		$7.85M Sell
1,207,802
-112,293
-9% -$772K ﹤0.01% 2519
2025
Q1 		$10.5M Buy
1,320,095
+1,127,995
+587% +$12.2M 0.01% 2138
2024
Q4 		$2.43M Buy
192,100
+85,606
+80% +$1.19M ﹤0.01% 3470
2024
Q3 		$1.48M Sell
106,494
-61,271
-37% -$874K ﹤0.01% 3963
2024
Q2 		$2.31M Buy
167,765
+138,757
+478% +$2.03M ﹤0.01% 3414
2024
Q1 		$479K Buy
+29,008
New +$434K ﹤0.01% 4859
2023
Q4 		– Sell
-35,786
Closed -$439K – 6167
2023
Q3 		$439K Sell
35,786
-452,338
-93% -$5.9M ﹤0.01% 4739
2023
Q2 		$5.83M Buy
488,124
+268,454
+122% +$3.51M ﹤0.01% 2529
2023
Q1 		$2.94M Buy
+219,670
New +$4.29M ﹤0.01% 3070
2022
Q3 		– Sell
-17,555
Closed -$314K – 7137
2022
Q2 		$314K Sell
17,555
-157,168
-90% -$1.62M ﹤0.01% 5318
2022
Q1 		$1.73M Buy
+174,723
New +$2.31M ﹤0.01% 4024
2021
Q4 		– Sell
-177,945
Closed -$4.22M – 6901
2021
Q3 		$4.22M Buy
+177,945
New +$4.26M ﹤0.01% 3059

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Millennium Management's DAWN Position: Q1 2026 in Review

Millennium Management increased its Day One Biopharmaceuticals (DAWN) stake by 43% in Q1 2026, buying an estimated $8.14M and bringing the position to 1,927,557 shares worth $41.3M. The position accounts for 0.02% of the portfolio, ranked #969.

Millennium Management first reported a position in DAWN in Q3 2021 and has held it in 15 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Millennium Management held 1,927,557 shares of Day One Biopharmaceuticals worth $41.3M as of Q1 2026.
  • Millennium Management bought 577,638 Day One Biopharmaceuticals shares in Q1 2026, an estimated $8.14M.
  • Day One Biopharmaceuticals made up 0.02% of Millennium Management's portfolio in Q1 2026, its #969 holding.
  • Millennium Management first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 15 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.